Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1β. - Hommel U; Hurth K; Rondeau JM; Vulpetti A; Ostermeier D; Boettcher A; Brady JP; Hediger M; Lehmann S; Koch E; Blechschmidt A; Yamamoto R; et al. (Nature communications, 2023)